Search In this Thesis
   Search In this Thesis  
العنوان
Possible beneficial effects of benfotiamine, a thiamine derivative, in isoproterenol-induced myocardial infarction in rats /
الناشر
Omnia Farouk Abdelmonem Hassan ,
المؤلف
Omnia Farouk Abdelmonem Hassan
هيئة الاعداد
باحث / Omnia Farouk Abd El-Monem Hassan
مشرف / Aiman Saad El-Khatib
مشرف / Lamiaa Ahmed Ahmed
مشرف / Omneya Osama Galal
تاريخ النشر
2020
عدد الصفحات
134 P. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الصيدلة ، علم السموم والصيدلانيات (المتنوعة)
تاريخ الإجازة
7/2/2020
مكان الإجازة
جامعة القاهرة - كلية الصيدلة - (Pharmacology and Toxicology)
الفهرس
Only 14 pages are availabe for public view

from 165

from 165

Abstract

Acute myocardial infarction (AMI) remains the most common cause of morbidity and mortality worldwide.The present study was directed to investigate the beneficial effects of pre- and post-treatments with benfotiamine in isoproterenol (ISO)-induced MI in rats. Myocardial heart damage was induced by subcutaneous injection of ISO (150 mg/kg) once daily for two consecutive days. Benfotiamine (100 mg/kg/day) was given orally for two weeks before or after ISO treatment. ISO administration revealed significant changes in electrocardiographic recordings, elevation of levels of cardiac enzymes; creatinine kinase (CK-MB) and troponin-I (cTn-I), and perturbation of markers of oxidative stress; nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD) and glutathione peroxidase (GPx) and markers of inflammation; protein kinase C (PKC), nuclear factor-kappa B (NF-{uF06B}B) and metalloproteinase-9 (MMP-9).The apoptotic markers (caspase-8 and p53) were also significantly elevated in ISO groups in addition to histological alterations. Groups treated with benfotiamine pre- and post-ISO administration showed significant decrease in cardiac enzymes levels and improvement of oxidative stress, inflammatory and apoptotic markers compared to the ISO groups. The current study highlights the potential role of benfotiamine as a promising agent for prophylactic and therapeutic interventions in myocardial damage in several cardiovascular disorders via NADPH oxidase inhibition